Dimitrov D - Search Results

1

The Cost-Effectiveness of Financial Incentives for Viral Suppression: HPTN 065 Study.

Adamson B, El-Sadr W, Dimitrov D, Gamble T, Beauchamp G, Carlson JJ, Garrison L Jr, Donnell D. Adamson B, et al. Among authors: dimitrov d. Value Health. 2019 Feb;22(2):194-202. doi: 10.1016/j.jval.2018.09.001. Epub 2018 Nov 2. Value Health. 2019. PMID: 30711064 Free PMC article.

2

Beating the placebo in HIV prevention efficacy trials: the role of the minimal efficacy bound.

Dimitrov DT, Mâsse BR, Boily MC. Dimitrov DT, et al. J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):95-101. doi: 10.1097/QAI.0b013e3182785638. J Acquir Immune Defic Syndr. 2013. PMID: 23075921 Free PMC article.

3

Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness.

Dimitrov D, Boily MC, Brown ER, Hallett TB. Dimitrov D, et al. PLoS One. 2013 Nov 25;8(11):e80927. doi: 10.1371/journal.pone.0080927. eCollection 2013. PLoS One. 2013. PMID: 24282559 Free PMC article. Review.

4

High incidence is not high exposure: what proportion of prevention trial participants are exposed to HIV?

Dimitrov D, Donnell D, Brown ER. Dimitrov D, et al. PLoS One. 2015 Jan 8;10(1):e0115528. doi: 10.1371/journal.pone.0115528. eCollection 2015. PLoS One. 2015. PMID: 25569838 Free PMC article.

5

A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population.

Dimitrov DT, Kiem HP, Jerome KR, Johnston C, Schiffer JT. Dimitrov DT, et al. Sci Rep. 2016 Feb 24;6:22183. doi: 10.1038/srep22183. Sci Rep. 2016. PMID: 26908162 Free PMC article.

6

PrEP Adherence Patterns Strongly Affect Individual HIV Risk and Observed Efficacy in Randomized Clinical Trials.

Dimitrov DT, Mâsse BR, Donnell D. Dimitrov DT, et al. J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):444-51. doi: 10.1097/QAI.0000000000000993. J Acquir Immune Defic Syndr. 2016. PMID: 26990823 Free PMC article.

7

The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review.

Adamson B, Dimitrov D, Devine B, Barnabas R. Adamson B, et al. Among authors: dimitrov d. Pharmacoecon Open. 2017 Mar;1(1):1-12. doi: 10.1007/s41669-016-0009-9. Epub 2017 Jan 30. Pharmacoecon Open. 2017. PMID: 28367539 Free PMC article.

8

Recruitment of Female Sex Workers in HIV Prevention Trials: Can Efficacy Endpoints Be Reached More Efficiently?

Wood D, Lancaster KE, Boily MC, Powers KA, Donnell D, Cohen MS, Dimitrov DT. Wood D, et al. Among authors: dimitrov dt. J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):350-357. doi: 10.1097/QAI.0000000000001603. J Acquir Immune Defic Syndr. 2018. PMID: 29206720 Free PMC article. Clinical Trial.

9

In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?

Mitchell KM, Dimitrov D, Hughes JP, Xia F, Donnell D, Amico KR, Bokoch K, Chitwarakorn A, Bekker LG, Holtz TH, Mannheimer S, Grant RM, Boily MC. Mitchell KM, et al. Among authors: dimitrov d. AIDS. 2018 Mar 27;32(6):809-818. doi: 10.1097/QAD.0000000000001766. AIDS. 2018. PMID: 29424774 Free PMC article.

10

Influence of model assumptions about HIV disease progression after initiating or stopping treatment on estimates of infections and deaths averted by scaling up antiretroviral therapy.

Sucharitakul K, Boily MC, Dimitrov D, Mitchell KM. Sucharitakul K, et al. Among authors: dimitrov d. PLoS One. 2018 Mar 19;13(3):e0194220. doi: 10.1371/journal.pone.0194220. eCollection 2018. PLoS One. 2018. PMID: 29554136 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,052 results

Search Page

Filters